Dr. Amalia Joanne Stefanou, MD

Dr. Stefanou practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Stefanou's NPI, 1477673630, was assigned on March 30, 2007. Dr. Stefanou graduated from Wayne State University School Of Medicine in 2006. Dr. Stefanou holds Florida license ME157784.

Dr. Stefanou's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Stefanou's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Stefanou is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Stefanou to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stefanou practices, 3 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Stefanou's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Stefanou is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Stefanou's licenses on file in 3 states: Florida, Michigan and Illinois.

Dmand AI lists colonoscopy and colon removal among the conditions Dr. Stefanou treats.

CMS data shows 51 Medicare services from Dr. Stefanou across 2 procedure codes in 2024, all of them office visits, for 91 Medicare patients. Medicare paid $6,551 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Stefanou in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have cancer, and 73% have high blood pressure. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stefanou's median patient age at 66, with 49% women.

In 2024, Dr. Stefanou wrote 105 Medicare Part D claims for 50 patients. 100% of them were for generic drugs. CMS names the drug for 89 of them, across 4 drugs with 11 or more claims each, at $436 in total drug cost. In 2023, CMS named 71 claims across 4 drugs.

Dr. Stefanou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stefanou as offering telehealth. CMS counts 55 procedures of colonoscopy by Dr. Stefanou, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Stefanou, published from 2011 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Colectomy and Colorectal Surgery. Dr. Stefanou has published most often in J Surg Res. Dr. Stefanou's most frequent co-authors are Craig A. Reickert, MD, Sophie Dessureault, MD, PhD and Seth Ian Felder, MD.

Dmand AI links Dr. Stefanou to 1 clinical trial.

CMS Open Payments shows 16 general payments to Dr. Stefanou from 4 drug and device companies from 2017 to 2024. Education make up the largest share, 82% of the total. Intuitive Surgical, Inc. paid the most, $7,224.

Dmand AI lists 2 awards for Dr. Stefanou, most recently CMS Stage 1 EHR in 2012.

Dr. Stefanou graduated from Wayne State University School Of Medicine in 2006. Dr. Stefanou is a member of ACS and ASCRS.

Dr. Stefanou is in network with 8 carriers, including Excellus BlueCross BlueShield, Health Alliance Plan and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.